fbioe-09-727298.pdf (509.25 kB)
Editorial: Advanced cell culture technologies to boost cell-based therapies.
journal contributionposted on 2022-01-17, 11:32 authored by Dominik Egger, Aldo R Boccaccini, Diego Correa, Cornelia Kasper, Fergal O'BrienFergal O'Brien
Approved cells and cellular products for cell-based therapy (CBT) applications carry a huge promise for the treatment of a broad variety of diseases and several (stem) cell therapies. However, the therapeutic potential of cells is not fully exploited at present. On the one hand, outdated culture conditions are still used during in vitro cultivation. On the other hand, technological hurdles block the way to efficient and safe cell-based therapy products. This Research Topic gathered articles about recent advances in cell culture technologies to increase the therapeutic properties of cells or the manufacturing processes for CBT.
European Research Council Advanced Grant ReCaP (agreement no 788,753)
CommentsThe original article is available at https://www.frontiersin.org/
Published CitationEgger D, Boccaccini AR, Correa D, Kasper C, O'Brien FJ. Editorial: Advanced cell culture technologies to boost cell-based therapies. Front Bioeng Biotechnol. 2021 19;9:727298.
Publication Date19 July 2021
- Tissue Engineering Research Group (TERG)
- Amber (Advanced Material & Bioengineering Research) Centre
- Anatomy and Regenerative Medicine
- Immunity, Infection and Inflammation
- Biomaterials and Regenerative Medicine
- Chemistry and Pharmaceutical Sciences
PublisherFrontiers Media SA
- Published Version (Version of Record)